Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-24-006397

Director acquired 6,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wasman Jane Director 2024-01-22 Grant or award +6,000 10,400 D
Derivatives
Wasman Jane Director 2024-01-22 Grant or award · Stock Option (Right to Buy) +10,000 10,000 D
Loading xslF345X05/tm243935-8_4seq1.xml…